- Previous Close
0.0200 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0200 - 0.0200 - 52 Week Range
0.0150 - 0.0300 - Volume
0 - Avg. Volume
125,994 - Market Cap (intraday)
10.798M - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.
www.preveceutical.com--
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Biotechnology
Industry
Recent News: PREV.CN
View More
Performance Overview: PREV.CN
Trailing total returns as of 2024-11-08, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PREV.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PREV.CN
View MoreValuation Measures
Market Cap
10.80M
Enterprise Value
14.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-292.67%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.26M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
234
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-117.17k